Financials
- Market Capitalization 2.21 B
- Employee 835
- Founded 1980
- CEO Douglas S. Ingram
- Website www.sarepta.com
- Headquarter Delaware, United States
- FIGI BBG000BCJ161
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-6.2
市销率
0.99
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1921 | PHVS Pharvaris N.V. - Ordinary Shares | 34.75 USD | -1.61% | -8.24% | +7.15% | +61.63% | 2.27 B USD | ||
| 1927 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 25.22 USD | -1.48% | -1.37% | -2.25% | -37.53% | 2.23 B USD | ||
| 1946 | MESO Mesoblast Limited - American Depositary Shares | 16.74 USD | -4.01% | +0.42% | +18.56% | +28.28% | 2.17 B USD | ||
| 1949 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.05 USD | -1.47% | -3.66% | +9.04% | +34.53% | 2.14 B USD |